Management of Subarachnoid Hemorrhage Due to Apixaban with Post-Trauma

Initial Assessment and Management

The American College of Cardiology recommends immediate discontinuation of apixaban in patients with traumatic subarachnoid hemorrhage as this represents a critical site bleeding event 1, 2
Assessing hemodynamic stability, neurological status, and severity of bleeding is crucial to guide management decisions, as suggested by Critical Care 3
Measuring anti-factor Xa activity, if available, can confirm apixaban effect and guide reversal strategy, according to Critical Care 3, 4
Providing supportive care, including airway management, blood pressure control, and volume resuscitation as needed, is recommended by the American College of Cardiology 1

The American College of Cardiology recommends administering andexanet alfa, a specific reversal agent for apixaban, for life-threatening subarachnoid hemorrhage 1, 2
Andexanet alfa can be administered in low doses (400 mg IV bolus followed by 4 mg/min infusion for up to 120 minutes) if the last dose was ≥8 hours ago or ≤5 mg taken <8 hours ago, as suggested by the American College of Cardiology 1
High-dose prothrombin complex concentrate (25-50 U/kg) can be administered if andexanet alfa is unavailable, according to Critical Care 3, 4

The American College of Cardiology suggests determining if there is a continued clinical indication for anticoagulation before restarting 1
For patients with high thrombotic risk, resuming anticoagulation after 7-14 days may be considered if bleeding has been controlled and risk of rebleeding is low, as recommended by the American College of Cardiology 1
The decision to restart anticoagulation should balance thrombotic risk against rebleeding risk, according to the American College of Cardiology 1, 2

Initiating thromboprophylaxis as soon as possible after bleeding is controlled is recommended by Critical Care 3, 4
Being aware that prothrombin complex concentrate carries an increased risk of both venous and arterial thrombosis during the recovery period is crucial, as suggested by Critical Care 3, 4